Table 3.
SBP category (mm Hg) | ‘Fit’ | ‘Mild frailty’ | ‘Moderate frailty’ | ‘Severe frailty’ | |||||
---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | ||
Not Treated with Antihypertensive Medications | |||||||||
Men | <110 | 1.71 (1.42 to 2.05) | <0.001 | 1.96 (1.66 to 2.30) | <0.001 | 2.05 (1.69 to 2.47) | <0.001 | 1.78 (1.21 to 2.64) | 0.004 |
110-119 | 1.29 (1.13 to 1.47) | <0.001 | 1.47 (1.31 to 1.65) | <0.001 | 1.58 (1.36 to 1.84) | <0.001 | 1.39 (1.06 to 1.82) | 0.015 | |
120-139 | Reference | Reference | Reference | Reference | |||||
140-159 | 0.83 (0.76 to 0.90) | <0.001 | 0.85 (0.78 to 0.92) | <0.001 | 0.88 (0.77 to 1.00) | 0.052 | 1.28 (1.01 to 1.61) | 0.039 | |
≥160 | 0.87 (0.76 to 0.99) | 0.029 | 1.01 (0.87 to 1.17) | 0.876 | 1.15 (0.91 to 1.46) | 0.239 | 2.32 (1. 57 to 3. 45) | <0.001 | |
Women | <110 | 1.63 (1.35 to 1.95) | <0.001 | 1.61 (1.38 to 1.88) | <0.001 | 2.11 (1.77 to 2.53) | <0.001 | 2.00 (1.55 to 2.58) | <0.001 |
110-119 | 1.26 (1.10 to 1.44) | 0.001 | 1.24 (1.12 to 1.39) | <0.001 | 1.43 (1.25 to 1.64) | <0.001 | 1.47 (1.20 to 1.82) | <0.001 | |
120-139 | Reference | Reference | Reference | Reference | |||||
140-159 | 0.73 (0.67 to 0.80) | <0.001 | 0.80 (0.74 to 0.87) | <0.001 | 0.90 (0.82 to 0.99) | 0.039 | 0.85 (0.72 to 1.01) | 0.062 | |
≥160 | 0.82 (0.72 to 0.92) | 0.001 | 0.81 (0.72 to 0.92) | 0.001 | 0.93 (0.79 to 1.11) | 0.423 | 0.79 (0.56 to 1.11) | 0.176 | |
Treated with Antihypertensive Medications | |||||||||
Men | <110 | 2.02 (1.54 to 2.66) | <0.001 | 2.51 (2,16 to 2.91) | <0.001 | 2.00 (1.71 to 2.33) | <0.001 | 1.62 (1.25 to 2.09) | <0.001 |
110-119 | 1.54 (1.30 to 1.83) | <0.001 | 1.45 (1.32 to 1.60) | <0.001 | 1.44 (1.29 to 1.61) | <0.001 | 1.31 (1.11 to 1.53) | 0.001 | |
120-139 | Reference | Reference | Reference | Reference | |||||
140-159 | 0.78 (0.71 to 0.85) | <0.001 | 0.83 (0.78 to 0.88) | <0.001 | 0.89 (0.82 to 0.96) | 0.004 | 0.89 (0.77 to 1.03) | 0.112 | |
≥160 | 0.98 (0.85 to 1.13) | 0.748 | 1.04 (0.94 to 1.16) | 0.436 | 1.18 (1.01 to 1.37) | 0.028 | 1.21 (0.90 to 1.63) | 0.212 | |
Women | <110 | 1.86 (1.39 to 2.47) | <0.001 | 1.98 (1.67 to 2.35) | <0.001 | 2.34 (1.98 to 2.77) | <0.001 | 1.98 (1.53 to 2.56) | <0.001 |
110-119 | 1.48 (1.23 to 1.79) | <0.001 | 1.46 (1.30 to 1.63) | <0.001 | 1.55 (1.38 to 1.75) | <0.001 | 1.44 (1.24 to 1.70) | <0.001 | |
120-139 | Reference | Reference | Reference | Reference | |||||
140-159 | 0.76 (0.70 to 0.84) | <0.001 | 0.79 (0.74 to 0.84) | <0.001 | 0.81 (0.75 to 0.87) | <0.001 | 0.80 (0.72 to 0.89) | <0.004 | |
≥160 | 0.85 (0.75 to 0.96) | 0.011 | 0.91 (0.83 to 1.00) | 0.068 | 0.95 (0.86 to 1.06) | 0.401 | 0.97 (0.82 to 1.15) | 0.733 |
Figures are hazard ratios (HR) and 95% confidence intervals adjusted for age, diastolic blood pressure, comorbidity, total cholesterol, smoking and anti-hypertensive treatment.